Actively Recruiting
Post-Approval Evaluation of the PALMAZ MULLINS XD Pulmonary Stent for Treating Pulmonary Artery Stenosis
Led by Cordis US Corp. · Updated on 2026-10-02
35
Participants Needed
8
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This clinical investigation focuses on patients with pulmonary artery stenosis and evaluates the real-world clinical outcomes of the PALMAZ MULLINS XD Pulmonary Stent. It is a prospective, single-arm, multi-center, post-approval study designed to observe the performance and safety of this device in everyday medical use. The study plans to enroll between 35 and 75 subjects across up to 11 U.S. sites during a two-year enrollment period. All enrolled participants will be treated with the PALMAZ MULLINS XD Pulmonary Stent, a balloon-expandable, laser-cut device made from stainless steel tubing. The stent comes in five different unexpanded lengths and is indicated specifically for non-emergency treatment of pulmonary artery stenosis in pediatric patients weighing at least 10 kg with two ventricle anatomy. The study collects data from the time of the device implant procedure through hospital discharge. Participants will be observed from the device implant during the index procedure until discharge, typically within about 48 hours after the procedure ends. Researchers will assess technical success, defined as successful device use without the need for additional unplanned surgery or re-intervention. They will also measure patency by looking at the increase in the stented vessel diameter and monitor any serious adverse events during this period. The total participation duration aligns with the hospital stay following implantation.
CONDITIONS
Brief Title
Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis
Research Team
J
Jenny Jimenez
R
Rajesh Nathan
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here